Intracranial Artery Occlusion With Infarction (Disorder) Clinical Trial
Official title:
A Prospective ,Multicenter, Registry Study of RECO in the Endovascular Treatment of Acute Ischemic Stroke
Investigate Reco ® ,the first clot retriever in china as the primary therapyand remedies in the real world.
Endovascular thrombectomy (EVT) is effective and safe for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) in major clinical trials. Whether the benefit of EVT in randomized trials could be generalized to clinical practice, especially in developing countries, remains unknown. The Registry was established to evaluate the utilization, and subsequent outcomes of EVT treated AIS patients. This study is a multi-center, prospective registry study initiated by researchers, to investigate Reco ® ,the first clot retriever in china as the primary therapyand remedies in the real world. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03370939 -
Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke
|
||
| Recruiting |
NCT04151589 -
Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT): Phase Two
|
N/A |